Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs for the reduction of scarring and acceleration of healing, announces that Professor Mark Ferguson, Chief Executive Officer, will be presenting at Cowen and Company’s 28th Annual Health Care Conference on Tuesday 18th March at 13:40 ET (17:40 GMT).
This presentation will be available via live webcast on the Company's website at http://www.renovo.com.
For further information please contact:
Renovo Group plc Simon Bielecki, VP Communications +44 (0) 161 606 7328
Printer-friendly version